- Home
- CUTR vs PPBT Comparison
CUTR vs PPBT Comparison
Compare CUTR & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUTR
- PPBT
- Stock Information
- Founded
- CUTR 1988
- PPBT 2010
- Country
- CUTR United States
- PPBT Israel
- Employees
- CUTR N/A
- PPBT N/A
- Industry
- CUTR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- PPBT Biotechnology: Pharmaceutical Preparations
- Sector
- CUTR Health Care
- PPBT Health Care
- Exchange
- CUTR Nasdaq
- PPBT Nasdaq
- Market Cap
- CUTR 9.2M
- PPBT 8.7M
- IPO Year
- CUTR 2004
- PPBT N/A
- Fundamental
- Price
- CUTR $0.43
- PPBT $3.17
- Analyst Decision
- CUTR Hold
- PPBT Strong Buy
- Analyst Count
- CUTR 3
- PPBT 2
- Target Price
- CUTR $3.00
- PPBT $126.50
- AVG Volume (30 Days)
- CUTR 174.3K
- PPBT 23.2K
- Earning Date
- CUTR 03-20-2025
- PPBT 03-07-2025
- Dividend Yield
- CUTR N/A
- PPBT N/A
- EPS Growth
- CUTR N/A
- PPBT N/A
- EPS
- CUTR N/A
- PPBT N/A
- Revenue
- CUTR $155,210,000.00
- PPBT N/A
- Revenue This Year
- CUTR N/A
- PPBT N/A
- Revenue Next Year
- CUTR $4.61
- PPBT N/A
- P/E Ratio
- CUTR N/A
- PPBT N/A
- Revenue Growth
- CUTR N/A
- PPBT N/A
- 52 Week Low
- CUTR $0.28
- PPBT $2.00
- 52 Week High
- CUTR $3.00
- PPBT $20.60
- Technical
- Relative Strength Index (RSI)
- CUTR 48.15
- PPBT 44.15
- Support Level
- CUTR $0.37
- PPBT $3.01
- Resistance Level
- CUTR $0.46
- PPBT $3.48
- Average True Range (ATR)
- CUTR 0.06
- PPBT 0.22
- MACD
- CUTR 0.00
- PPBT 0.03
- Stochastic Oscillator
- CUTR 37.50
- PPBT 52.63
About CUTR Cutera Inc.
Cutera Inc is a medical device company that specializes in designing, developing, manufacturing, marketing, and servicing laser and other energy-based aesthetics systems for practitioners internationally. Its products include enlighten, excel HR, excel V, Xeo and Trusculpt 3D among others. The company markets and sells its products under the trademarks such as Cutera, Acutip, Coolglide, Enlighten, Excel HR, Excel V, Genesis plus, Pico-genesis, Titan, Trusculpt, and Xeo among others. It derives the majority of its revenue from the United States segment. Its products enable medical practitioners to perform safe procedures including treatment for acne, body contouring, skin resurfacing and revitalization, hair and tattoo removal, removal of benign pigmented lesions, and vascular conditions.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.